OA3-3 Combinatorial CRISPR/Cas9 approaches targeting different steps in the HIV life cycle can prevent the selection of resistance

• M. Nijhuis,
• D. Jong, de,
• F. Wolters,
• E. Wiertz,
• R.J. Lebbink

Affiliations

M. Nijhuis

University Medical Center Utrecht, Medical Microbiology, Virology, Utrecht, Netherlands

D. Jong, de

University Medical Center Utrecht, Medical Microbiology, Virology, Utrecht, Netherlands

F. Wolters

University Medical Center Utrecht, Medical Microbiology, Virology, Utrecht, Netherlands

E. Wiertz

University Medical Center Utrecht, Medical Microbiology, Virology, Utrecht, Netherlands

R.J. Lebbink

University Medical Center Utrecht, Medical Microbiology, Virology, Utrecht, Netherlands